-
1
-
-
0034632863
-
Synthesis and structure-activity relationships of a new set of 2-arylpyrazolo[3,4-c]quinoline derivatives as adenosine receptor antagonists
-
Colotta, V., Catarzi, D., Varano, F., Cecchi, L., Filacchioni, G., Martini, C., Trincavelli, L. and Lucacchini, A, (2000) "Synthesis and structure-activity relationships of a new set of 2-arylpyrazolo[3,4-c]quinoline derivatives as adenosine receptor antagonists", J. Med. Chem. 10, 3118-3124.
-
(2000)
J. Med. Chem.
, vol.10
, pp. 3118-3124
-
-
Colotta, V.1
Catarzi, D.2
Varano, F.3
Cecchi, L.4
Filacchioni, G.5
Martini, C.6
Trincavelli, L.7
Lucacchini, A.8
-
2
-
-
0029977331
-
3 receptors
-
3 receptors", J. Med. Chem. 39, 2980-2989.
-
(1996)
J. Med. Chem.
, vol.39
, pp. 2980-2989
-
-
Van Rhee, A.M.1
Jiang, J.2
Melman, N.3
Olah, M.E.4
Stiles, G.L.5
Jacobson, K.A.6
-
4
-
-
0032417586
-
2a adenosine receptor agonists
-
2a adenosine receptor agonists", Med. Chem. Res. 8, 277-290.
-
(1998)
Med. Chem. Res.
, vol.8
, pp. 277-290
-
-
Mager, P.P.1
-
5
-
-
0027166948
-
Signalling via G-protein coupled receptors - Using adenosine receptors as an example
-
Fredholm, B.B., Gerwins, P., Johansson, B., Parkinson, F.E. and van der Ploeg, I. (1993) "Signalling via G-Protein coupled receptors - using adenosine receptors as an example", Drug Design and Discovery 9, 189-197.
-
(1993)
Drug Design and Discovery
, vol.9
, pp. 189-197
-
-
Fredholm, B.B.1
Gerwins, P.2
Johansson, B.3
Parkinson, F.E.4
Van Der Ploeg, I.5
-
6
-
-
0033970811
-
Neural networks are useful tools for drug design
-
Schneider, G. (2000) "Neural networks are useful tools for drug design", Neural Netw. 13, 15-60.
-
(2000)
Neural Netw.
, vol.13
, pp. 15-60
-
-
Schneider, G.1
-
7
-
-
0032855269
-
A comparison of backpropagation and generalized-regression genetic-neural network models
-
Mager, P.P. and Reinhardt, R. (1999) "A comparison of backpropagation and generalized-regression genetic-neural network models", Drug Design and Discovery 16, 49-53.
-
(1999)
Drug Design and Discovery
, vol.16
, pp. 49-53
-
-
Mager, P.P.1
Reinhardt, R.2
-
9
-
-
0000665302
-
The extrathermodynamic approach to drug design
-
Fujita, T. (1990) "The extrathermodynamic approach to drug design", Compr. Med. Chem. 4, 497-560.
-
(1990)
Compr. Med. Chem.
, vol.4
, pp. 497-560
-
-
Fujita, T.1
-
11
-
-
0023751431
-
Comparative molecular field analysis (CoMFA)
-
Cramer, R.D., Patterson, D.E. and Abraham, D.J. (1988) "Comparative molecular field analysis (CoMFA)", J. Am. Chem. Soc. 110, 5959-5967.
-
(1988)
J. Am. Chem. Soc.
, vol.110
, pp. 5959-5967
-
-
Cramer, R.D.1
Patterson, D.E.2
Abraham, D.J.3
-
12
-
-
0029618445
-
Molecular simulation of 8-styrylxanthines
-
Mager, P.P., Reinhardt, R., Richter, M., Walther, H. and Rockel, B. (1995) "Molecular simulation of 8-styrylxanthines", Drug Design and Discovery 13, 89-107.
-
(1995)
Drug Design and Discovery
, vol.13
, pp. 89-107
-
-
Mager, P.P.1
Reinhardt, R.2
Richter, M.3
Walther, H.4
Rockel, B.5
-
13
-
-
0028308315
-
2 agonists: Structure-activity relationships of 2-(cycloalkylalkynyl)adenosine derivatives
-
2 agonists: structure-activity relationships of 2-(cycloalkylalkynyl)adenosine derivatives", Eur. J. Med. 29, 369-380.
-
(1994)
Eur. J. Med.
, vol.29
, pp. 369-380
-
-
Mager, P.P.1
-
14
-
-
0010556622
-
A random numbers experiment to simulate resample model evaluation
-
Mager, P.P. (1996) "A random numbers experiment to simulate resample model evaluation", J. Chemometrics 10, 221-240.
-
(1996)
J. Chemometrics
, vol.10
, pp. 221-240
-
-
Mager, P.P.1
|